Bionano Genomics Announces UK Footprint Expansion with Adoption of its Saphyr® System for Optical Genome Mapping in Two Genetic Laboratory Hubs within the United Kingdom's National Health ServiceGlobeNewsWire • 02/02/22
4 Under-the-Radar Stocks With 319% to 645% Upside in 2022, According to Wall StreetThe Motley Fool • 01/29/22
Bionano Genomics Announces Publication of the First Study to Combine OGM and NGS to Evaluate Myeloid CancersGlobeNewsWire • 01/26/22
UPDATE -- Bionano Genomics Announces its Support for the ACMG Foundation for Genetic and Genomic Medicine and its Next Generation Fellowship & Residency Training Awards ProgramGlobeNewsWire • 01/20/22
Bionano Genomics Announces its Support for the AGMG Foundation for Genetic and Genomic Medicine and its Next Generation Fellowship & Residency Training Awards ProgramGlobeNewsWire • 01/20/22
Bionano Genomics Hosts Final Day of 2022 Symposium with Presentations Demonstrating the Combined Detection Power of OGM and NGSGlobeNewsWire • 01/13/22
Bionano Genomics Hosts Day 3 of 2022 Symposium with New Research Demonstrating Applications of OGM in Solid Tumor AnalysisGlobeNewsWire • 01/12/22
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 ResultsGlobeNewsWire • 01/12/22
Bionano Genomics Hosts Day 2 of 2022 Symposium with New Research Demonstrating How OGM Detects Known and Novel Variants in Hematologic MalignanciesGlobeNewsWire • 01/11/22
UPDATE - Bionano Genomics Hosts Day 1 of 2022 Symposium with Six Presentations Highlighting the Superior Performance of OGM in Variant Detection for Constitutional Genetic DiseasesGlobeNewsWire • 01/11/22
Bionano Genomics Hosts Day 1 of 2022 Symposium with Six Presentations Highlighting the Superior Performance of OGM in Variant Detection for Constitutional Genetic DiseasesGlobeNewsWire • 01/10/22
Bionano Announces Prototype for its Next Single Molecule Imaging System for OGMGlobeNewsWire • 12/29/21
University Hospitals Leuven in Belgium Outlines their Menu Expansion Plans for Optical Genome Mapping as One of their Primary Analyses in Leukemias & Lymphomas and Genetic DiseaseGlobeNewsWire • 12/23/21